Carcinogenesis and Ito cell
癌变与伊藤细胞
基本信息
- 批准号:08670598
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Administration of a choline deficient L-amino acid defined (CDAA) diet for 16 weeks led to the development of preneoplastic lesions that were positive for the placental form of glutathione S-transferase (GSTP) and induced hepatocellular carcinoma in 90% of rats after one year. Prolyl 4-hydroxylase inhibitor (HOE 077, 200 ppm) significantly reduced the size and incidence of preneoplastic lesions after 16 weeks and also the incidence of HCC (50%) in rats fed a CDAA diet for one year by the inactivation of Ito cell resulting in the prevention of fibrosis.Injection of pig serum into rats twice a week for 8 weeks induced.TGF-beta_1 mRNA expression and protein production resulting in liver fibrosis without parenchymal cell injury. Administration of a choline deficient L-amino acid defined (CDAA) diet for 6 weeks with or without pig serum pretreatment led to the development of preneoplastic lesions that were positive for the placental form of glutathione S- transferase (GSTP). Pig serum pretreatment induced more activated stellate cells with increased TGF-beta_1, mRNA expression and protein production in the livers of rats subsequently fed a CDAA diet for 6 weeks compared to rats fed the CDAA diet alone.These results indicate that pre-existing fibrosis with the activated stellate cells accelerates the development of preneoplastic lesions in a CDAA.diet model and that TGF-beta_1 induced by pig serum treatment failed to prevent the development of preneoplastic lesions in a CDAA-diet model.Cancer cell seems to prevent the activation of Ito cell in co-culture system but further examinations are necessary.
给药16周的胆碱缺乏的L-氨基酸定义(CDAA)饮食导致了麦芽糖化剂S-转移酶(GSTP)的胎盘形式呈阳性的肿瘤性病变的发展,并诱导的肝细胞癌在90%的大鼠中均为肝细胞癌年。脯氨酰4-羟化酶抑制剂(HOE 077,200 ppm)显着降低了16周后的肿瘤性病变的大小和发生率,并且由于ITO细胞的失活而在CDAA饮食中的HCC(50%)的发生率(50%)降低了一年在预防纤维化中,猪血清每周两次注射猪血清诱导8周。TGF-BETA_1 mRNA表达和蛋白质产生,导致肝纤维化无实质性细胞损伤。在有或没有猪血清预处理的情况下,施用胆碱缺乏的L-氨基酸(CDAA)饮食6周,导致牙骨质病变的发展,这些病变对谷胱甘肽S-转移酶(GSTP)的胎盘形式呈阳性。与单独喂食CDAA饮食相比活化的星状细胞加速了cdaa.diet模型中肿瘤性病变的发展,并且猪血清处理诱导的TGF-BETA_1无法阻止CDAA-DIET模型中质量塑性病变的发展。CANCANCER细胞似乎可以防止ITO的激活激活共培养系统中的细胞,但需要进一步检查。
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isao Sakaida: "Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet." Journal of Hepatology. 28. 298-306 (1998)
Isao Sakaida:“草药 Sho-saiko-to (TJ-9) 可预防由缺乏胆碱的 L-氨基酸饮食引起的大鼠肝硬化的肝纤维化和酶改变病变。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakaida I.: "Fibrosis accelerates the development of enzyme-altered lesions in the rat liver." Hepatology. 28. 1247-1252 (1998)
Sakaida I.:“纤维化加速了大鼠肝脏酶改变病变的发展。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Isao Sakaida: "The prolyl4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells,reducing procollagen geneexpression in rat liver fibrosis induced by choline deficient L-amino acid-defined diet." Hepatology. 23. 755-763 (1996)
Isao Sakaida:“脯氨酰 4-羟化酶抑制剂 HOE 077 可防止 Ito 细胞活化,减少由缺乏胆碱的 L-氨基酸饮食诱导的大鼠肝纤维化中的前胶原基因表达。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Isao Sakaida: "Carcinogenesis and fibrosis" Bull.Yamaguchi Med.Sch.(in press).
Isao Sakaida:“癌变和纤维化”Bull.Yamaguchi Med.Sch.(印刷中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakaida I.: "Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis nduced by a choline-deficient L-amino acid-defined diet." J.Hepatol.28. 298-306 (1998)
Sakaida I.:“草药 Sho-saiko-to (TJ-9) 可预防由缺乏胆碱的 L-氨基酸饮食引起的大鼠肝硬化的肝纤维化和酶改变病变。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAKAIDA Isao其他文献
SAKAIDA Isao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAKAIDA Isao', 18)}}的其他基金
The development research of liver regeneration therapy used bone marrow drived liver repaired cell
骨髓驱动肝修复细胞肝再生治疗的进展研究
- 批准号:
20H03663 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The development of liver regeneration therapy with higher therapeutic effects on liver cirrhosis using a middle-large size liver cirrhosis model.
利用中大型肝硬化模型开发对肝硬化具有更高治疗效果的肝再生疗法。
- 批准号:
17H04162 - 财政年份:2017
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new gene transfer system for small fish
小型鱼类新基因转移系统的开发
- 批准号:
22659148 - 财政年份:2010
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Mechanism of fibrolysis and effect on cancer by autologus bone marrow cell infusion therapy for liver cirrhosis
自体骨髓细胞输注治疗肝硬化的纤维化机制及抗癌作用
- 批准号:
19390199 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The development of cell therapy for liver fibrolysis and prevention of carcinogenesis using bone marrow cell transplantaion
利用骨髓细胞移植治疗肝纤维化和预防癌变的细胞疗法的发展
- 批准号:
16590597 - 财政年份:2004
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cross-talk of Ito(stellate) cell and preneoplastic and cancer cells of hepatocarcinogenesis
伊藤星状细胞与肝癌癌前及癌细胞的串扰
- 批准号:
11670507 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
基于单细胞组学的癌症异质性解析和个性化给药方案研究
- 批准号:62373093
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
癌症细胞膜上多肽原位自组装及其在免疫调节剂前药递送中的应用
- 批准号:32301103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多组学特征整合的癌症诊疗靶点识别方法研究
- 批准号:62302088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
可代谢调控弱碱性钠盐纳米材料的控制合成及其在增强癌症免疫治疗中的应用
- 批准号:52372273
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
双重生物响应性自佐剂聚多肽载体构建高效mRNA癌症疫苗
- 批准号:52373299
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
9th International Conference on Relaxin, Related Peptides, and Receptors
第九届松弛素、相关肽和受体国际会议
- 批准号:
480623 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Miscellaneous Programs
The role of amphiregulin in mediating radiation cystitis in cancer survivors
双调蛋白在介导癌症幸存者放射性膀胱炎中的作用
- 批准号:
10636699 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别: